Other SCFAs, such as propionate, acts directly on γδ T-cell subpopulation to inhibit their production of interleukin-17 (IL-17) in both mice and humans (i.e. patients with inflammatory bowel disease) [19]. The gene discussed is IL17A; the disease is inflammatory bowel disease.